Key result
The vasoconstrictive peripheral effect of high-dose clonidine partly offset its centrally mediated arterial pressure-lowering effect (81.3 mmHg with peripheral effect vs 70.7 mmHg without, P<0.05).
Why the study?
The extent to which peripheral vasoconstriction from clonidine offsets its centrally mediated arterial pressure-lowering effect remains unknown.
Does intravenous clonidine exert a peripheral vasoconstrictive effect that offsets its centrally mediated arterial pressure-lowering effect in anesthetized rats?
Does intravenous clonidine exert a peripheral vasoconstrictive effect that offsets its centrally mediated arterial pressure-lowering effect in anesthetized rats?
Absolute Event Rate: 81.3% vs 70.7%
p-value: p=<0.05
In a rat model, the peripheral vasoconstrictive effect of high-dose intravenous clonidine partially offsets its centrally mediated arterial pressure-lowering effect.
Clonidine's peripheral vasoconstriction may offset central AP reduction in rats; leaves open translation to human hypertension therapy.
Clonidine is a first-generation central antihypertensive that reduces sympathetic nerve activity (SNA). Although clonidine also exerts peripheral vasoconstriction, the extent to which this vasoconstriction offsets the centrally mediated arterial pressure (AP)-lowering effect remains unknown. In anesthetized rats (n = 8), we examined SNA and AP responses to stepwise changes in carotid sinus pressure under control conditions and after intravenous low-dose (2 μg/kg) and high-dose clonidine (5 μg/kg). In the baroreflex equilibrium diagram analysis, the operating-point AP under the control condition was 115.2 (108.5-127.7) mmHg [median (25th-75th percentile range)]. While the operating-point AP after low-dose clonidine was not significantly different with or without the peripheral effect, the operating-point AP after high-dose clonidine was higher with the peripheral effect than without [81.3 (76.2-98.2) mmHg vs. 70.7 (57.7-96.9), P < 0.05]. The vasoconstrictive effect of clonidine partly offset the centrally mediated AP-lowering effect after high-dose administration.
No takes yet. Share an insight, caveat, or question.
Kawada et al. (2021) studied None (healthy rats) (n=8). Intravenous clonidine vs. Control condition (baseline) and simulated exclusion of peripheral effect was evaluated on Operating-point arterial pressure after high-dose clonidine (with vs without peripheral effect) (p=<0.05). The vasoconstrictive peripheral effect of high-dose clonidine partly offset its centrally mediated arterial pressure-lowering effect (81.3 mmHg with peripheral effect vs 70.7 mmHg without, P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: